Month: October 2015
-
Biotech, Accelerator to Partner on Glaucoma Treatment
30 October 2015. A new eye-drop treatment for the underlying causes of glaucoma is being developed in a collaboration between a biotechnology enterprise spun-off from Northwestern University and a company that acquires biomedical research assets. Financial aspects of the deal between Mannin Research Inc. in Toronto, Ontario, Canada and Q BioMed Inc. in New York…
-
New Design Advances Lithium-Air Battery
30 October 2015. A research group at University of Cambridge in the U.K. unveiled a new design that meets some of the obstacles plaguing lithium-air batteries, considered a major improvement over lithium-ion batteries now used to power mobile devices, computers, and electric cars. The team from the lab of chemistry professor Clare Grey published its…
-
Trial Underway Testing Breast Cancer Surgical Aid
29 October 2015. An early-stage clinical trial is recruiting participants to test a peptide that illuminates tumor cells to be removed in breast cancer surgery. The study is testing the experimental product made by Avelas Biosciences Inc., a biotechnology company in La Jolla, California. The clinical trial is enrolling individuals with primary, non-recurring breast cancer,…
-
Faster Process Devised for Skin-Patch Sensors
29 October 2015. Engineers at University of California in San Diego developed a process that simplifies production of flexible electronic sensors worn on the skin for medical diagnostics. The team from the lab of bioengineering professor Todd Coleman published its findings in a recent issue of the journal Sensors. The UC-San Diego team was seeking…
-
Heart-Powered Leadless Pacemaker in Development
28 October 2015. A heart pacemaker — the device regulating heartbeats of people with slow or irregular heart rhythms — is being designed to draw power from the beating heart itself and work with next-generation devices that operate inside the heart without wires or leads. Engineers from University at Buffalo in New York, in the…
-
Univ Lab, Spin-Off Developing Drug from Turmeric
28 October 2015. A university biochemistry lab and spin-off enterprise developing drugs from plants are collaborating on a process for extracting a key ingredient for an anti-inflammatory compound from the common spice turmeric. The project, bringing together the lab of biochemistry professor David Gang at Washington State University and Botanisol LLC in Scottsdale, Arizona, is…
-
Mobile App Collecting Placenta Health Data
27 October 2015. A new iPhone app allows women to report on the health of their placentas as their pregnancies develop, in a research study of placenta health to help reduce fetal death. The app is designed by researcher Harvey Kliman at Yale University medical school, director of the school’s reproductive and placental research unit.…
-
Survey ends 20 November 2015
Updated 21 November 2015. The survey is now closed. Thank you for taking part. 26 October 2015. Our survey conducted with with researcher Paige Brown Jarreau ends this Friday, 20 November 2015. If you planned on taking part in the survey, please do so today. By participating, you’ll be helping me improve Science and Enterprise and…
-
Gene Editing Licensed for Inherited Disease Treatments
26 October 2015. A Boston biotechnology company is licensing gene-editing technologies from a nearby start-up to design treatments for cystic fibrosis and inherited blood disorders, including sickle cell disease. Vertex Pharmaceuticals, in Boston, received rights to techniques known as CRISPR-Cas9 in a deal that could bring CRISPR Therapeutics, founded in April 2014, as much as…
-
Two Current Drugs Shown Also to Promote Hair Growth
23 October 2015. Research originally designed to study hair loss from an autoimmune disorder, uncovered two drugs now on the market that in lab tests show they may also regrow hair. Findings of the study led by molecular dermatology professor Angela Christiano at Columbia University in New York appear in today’s issue of the journal…